MTOR, mechanistic target of rapamycin kinase, 2475

N. diseases: 960; N. variants: 48
Disease: Seizures, Focal ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751495
Disease: Seizures, Focal
Seizures, Focal 		0.010 Biomarker phenotype BEFREE Recently, the mTOR inhibitor everolimus was approved as adjunctive therapy for TSC-associated partial seizures. 31335226 2019